NL190266C - Aminozuuroplossing voor kankerpatienten. - Google Patents

Aminozuuroplossing voor kankerpatienten.

Info

Publication number
NL190266C
NL190266C NLAANVRAGE7906620,A NL7906620A NL190266C NL 190266 C NL190266 C NL 190266C NL 7906620 A NL7906620 A NL 7906620A NL 190266 C NL190266 C NL 190266C
Authority
NL
Netherlands
Prior art keywords
amino acid
acid solution
cancer patients
cancer
patients
Prior art date
Application number
NLAANVRAGE7906620,A
Other languages
English (en)
Dutch (nl)
Other versions
NL190266B (nl
NL7906620A (nl
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NL7906620A publication Critical patent/NL7906620A/nl
Publication of NL190266B publication Critical patent/NL190266B/xx
Application granted granted Critical
Publication of NL190266C publication Critical patent/NL190266C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7906620,A 1978-09-04 1979-09-04 Aminozuuroplossing voor kankerpatienten. NL190266C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10874978 1978-09-04
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (3)

Publication Number Publication Date
NL7906620A NL7906620A (nl) 1980-03-06
NL190266B NL190266B (nl) 1993-08-02
NL190266C true NL190266C (nl) 1994-01-03

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7906620,A NL190266C (nl) 1978-09-04 1979-09-04 Aminozuuroplossing voor kankerpatienten.

Country Status (10)

Country Link
JP (1) JPS5535049A (enExample)
AU (1) AU526207B2 (enExample)
CA (1) CA1134275A (enExample)
CH (1) CH642541A5 (enExample)
DE (1) DE2935709C2 (enExample)
FR (1) FR2434622A1 (enExample)
GB (1) GB2029220B (enExample)
IT (1) IT1194844B (enExample)
NL (1) NL190266C (enExample)
SE (1) SE448679B (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58500526A (ja) * 1981-04-17 1983-04-07 アメリカン ホスピタル サプライ コ−ポレ−シヨン 非経口栄養供給のための改良溶液
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
WO1993006834A1 (en) * 1991-10-07 1993-04-15 Otsuka Pharmaceutical Factory, Inc. Enteral preparation for cancer therapy
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
ES2184756T3 (es) * 1992-11-19 2003-04-16 Anticancer Inc Uso de metioninasa como agente antitumoral en quimioterapia antimetionina.
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
RU2125874C1 (ru) * 1994-07-04 1999-02-10 Казанский государственный университет им.В.И.Ульянова-Ленина Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
JP2000515874A (ja) * 1996-07-30 2000-11-28 ノバルテイス・ニユートリシヨン・アクチエンゲゼルシヤフト アミノ酸組成物、ならびに腫瘍の成長および転移の処置におけるその使用
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
RU2144821C1 (ru) * 1999-02-16 2000-01-27 Товарищество с ограниченной ответственностью Фирма "ГЛЕС" Противоопухолевое средство
ATE323479T1 (de) * 2000-06-16 2006-05-15 Matthias Dr Med Rath Zusammensetzung für die verhinderung der glattmuskelkrankheiten, die ascorbat, arginin und magnesium enthält
DE60028376T2 (de) * 2000-10-09 2007-06-06 Rath, Matthias, Dr. Therapeutische Kombination des Ascorbats mit Lysin und Arginin für Verhinderung und Behandlung des Krebses
US6974833B2 (en) 2001-01-16 2005-12-13 Matthias Rath Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003030890A1 (fr) * 2001-10-05 2003-04-17 Tetsuro Asao Activateurs du systeme immunitaire
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
JP2007529554A (ja) * 2004-03-19 2007-10-25 プロ−ファーマシューティカルズ,インク. 多価リガンド結合糖質ポリマーを用いた組成物、および該組成物による転移腫瘍の標的療法
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
KR101487848B1 (ko) 2005-07-29 2015-02-03 티마 파운데이션 알콜대사를 완화하고 알콜유도성 질환의 위험을 감소하기 위한 조성물
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
ES2891733T3 (es) 2007-03-28 2022-01-31 Univ Southern California Inducción de la resistencia diferencial al estrés y usos de la misma
EP2285218B1 (en) * 2008-04-24 2020-06-17 University Of Southern California, USC Stevens Dietary compositions and methods for protection against chemotherapy or radiotherapy
EP2676664B1 (en) * 2011-02-17 2017-06-21 EA Pharma Co., Ltd. Potentiator of antitumor activity of chemotherapeutic agent
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
BR112020002419A2 (pt) 2017-08-14 2020-07-28 Axcella Health Inc. aminoácido para o tratamento de doença do fígado
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
IT202000000442A1 (it) 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (enExample) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung

Also Published As

Publication number Publication date
CA1134275A (en) 1982-10-26
SE448679B (sv) 1987-03-16
AU5036879A (en) 1980-03-13
JPS5535049A (en) 1980-03-11
DE2935709A1 (de) 1980-03-13
IT7905216A0 (it) 1979-09-03
AU526207B2 (en) 1982-12-23
JPS6154007B2 (enExample) 1986-11-20
GB2029220B (en) 1983-03-30
CH642541A5 (de) 1984-04-30
NL190266B (nl) 1993-08-02
FR2434622B1 (enExample) 1983-04-15
IT1194844B (it) 1988-09-28
NL7906620A (nl) 1980-03-06
FR2434622A1 (fr) 1980-03-28
DE2935709C2 (de) 1986-02-06
GB2029220A (en) 1980-03-19
SE7907316L (sv) 1980-03-05

Similar Documents

Publication Publication Date Title
NL190266C (nl) Aminozuuroplossing voor kankerpatienten.
NO791140L (no) Tioetiansyrederivater.
NO792420L (no) Hudpleiepreparat.
NO801863L (no) Farmasoeytiske preparater.
FI791727A7 (fi) Menetelmä N-alkyloitujen aminoalkoholien valmistamiseksi.
NO154612C (no) Ildledningssystem for en kanon.
NL7903077A (nl) Magnetische gordel voor medische doeleinden.
NO153205C (no) Tannrensemiddel.
NL184722C (nl) Meercomponentencapsule voor tandtechnische doeleinden.
NL7701865A (nl) Werkwijze voor de bereiding van tereftaalzuur.
NL7607325A (nl) Zeilmast voor zeilski's.
NL188645C (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NO790313L (no) Farmasoeytisk opploesning.
NO792383L (no) Korrugert festeorgan.
NL184516C (nl) Werkwijze voor de bereiding van zouten van pyrodruivenzuur.
IT1164927B (it) Catodo per elettrolizzatori
NL7701695A (nl) Werkwijze voor de bereiding van 2.2-dimethyl- -3-(2'.2'-dichloorvinyl) cyclopropaan-1-carbon- zuur.
NL7902103A (nl) Emulgeerbare preparaten.
NL178002C (nl) Werkwijze voor de bereiding van di-n-propylazijnzuur.
NL184586C (nl) Niet-polariserend electrodestelsel voor geofysisch onderzoek.
NL7812598A (nl) Thioalkanoylalkaancarbonzuurverbindingen.
NL7901290A (nl) Farmaceutische preparaten.
NL7901293A (nl) Plaveisteen.
IT1122808B (it) Complesso di pattino di cingoli
IT7823834A0 (it) Nuovi composti farmaceutici.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
A85 Still pending on 85-01-01
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 19990904